Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DD76HZ
|
|||
| Drug Name |
SNF472
|
|||
| Synonyms |
Hexasodium phytate; UNII-ZBX50UG81V; 34367-89-0(Hexasodium phytate); ZBX50UG81V; 34367-89-0; sodium cyclohexane-1,2,3,4,5,6-hexayl hexakis(hydrogen phosphate); Inositol, hexakis(dihydrogen phosphate) hexasodium salt, myo-; Myo-inositol, hexakis(dihydrogen phosphate), hexasodium salt; Q27295268; scyllo-inositol,1,2,3,4,5,6-hexakis(dihydrogenphosphate),hexasodiumsalt; (1R,2R,3S,4S,5S,6S)-cyclohexane-(1,2,3,4,5,6)-hexaylhexakis(hydrogenphosphate),hexasodiumsalt
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Calcific uremic arteriolopathy [ICD-11: EB90.42 ] | Phase 3 | [1] | |
| Calciphylaxis [ICD-11: EB90.42] | Phase 3 | [1] | ||
| Company |
Sanifit
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C6H12Na6O24P6
|
|||
| Canonical SMILES |
C1(C(C(C(C(C1OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
|
|||
| InChI |
1S/C6H18O24P6.6Na/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15;;;;;;/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24);;;;;;/q;6*+1/p-6
|
|||
| InChIKey |
DHZIAGCFFSRULK-UHFFFAOYSA-H
|
|||
| CAS Number |
CAS 34367-89-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hydroxyapatite (HA) | Target Info | Binder | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04195906) Phase 3 Study of SNF472 for Calciphylaxis (Calciphyx). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Sanifit. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.